Ask AI
Bill115th CongressFiled May 19, 2017Health
H.R. 2557

Prostate Cancer Misdiagnosis Elimination Act of 2017

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to house amended, part i (Dec 6, 2017)


Prostate Cancer Misdiagnosis Elimination Act of 2017

This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

What just happenedDec 6, 2017

Placed on the Union Calendar, Calendar No. 331.

Who’s behind it

Rep. Bucshon, Larry [R-IN-8](R-IN)Sponsor
6 cosponsors3 D3 R
Read on Congress.gov
6cosponsors2committees16actions1related bills6subjects
  1. Dec 6, 2017CalendarsH12410

    Placed on the Union Calendar, Calendar No. 331.

  2. Dec 6, 2017DischargeH12300

    Committee on Ways and Means discharged.

    Ways and Means Committee
  3. Dec 6, 2017Committee5500

    Committee on Ways and Means discharged.

    Ways and Means Committee
  4. Dec 6, 2017CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.

    Energy and Commerce Committee
  5. Dec 6, 2017Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.

    Energy and Commerce Committee
  6. Oct 4, 2017Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  7. Oct 4, 2017Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  8. Sep 13, 2017Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  9. Sep 13, 2017Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  10. Jun 1, 2017Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  11. May 26, 2017Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  12. May 19, 2017IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  13. May 19, 2017IntroReferralH11100-A

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  14. May 19, 2017IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  15. May 19, 2017IntroReferralIntro-H

    Introduced in House

  16. May 19, 2017IntroReferral1000

    Introduced in House

Reported to House amended, Part IDec 6, 201718

Prostate Cancer Misdiagnosis Elimination Act of 2017

This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

Introduced in HouseMay 19, 2017

Prostate Cancer Misdiagnosis Elimination Act of 2017

This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

Prostate Cancer Misdiagnosis Elimination Act of 2017 — Informed